Mirati Therapeutics, Inc. (MRTX) Debt-to-equity % [USD] 2014 - 2023

Historical data

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Mirati Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from 2014 to 2023.
  • Mirati Therapeutics, Inc. Debt-to-equity for the quarter ending September 30, 2023 was 21.1 %, a 46.3% increase year-over-year.
Debt-to-equity, Quarterly (% [USD])
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 21.1 +6.69 +46.3% Sep 30, 2023
Q2 2023 19.8 +5.36 +37% Jun 30, 2023
Q1 2023 17.5 +1.9 +12.2% Mar 31, 2023
Q4 2022 16.1 +1.48 +10.2% Dec 31, 2022
Q3 2022 14.4 +1.34 +10.2% Sep 30, 2022
Q2 2022 14.5 +2.09 +16.9% Jun 30, 2022
Q1 2022 15.6 +5.98 +61.9% Mar 31, 2022
Q4 2021 14.6 +5.1 +53.9% Dec 31, 2021
Q3 2021 13.1 +2.39 +22.3% Sep 30, 2021
Q2 2021 12.4 +2.65 +27.2% Jun 30, 2021
Q1 2021 9.66 +0.8 +9.03% Mar 31, 2021
Q4 2020 9.47 +0.51 +5.69% Dec 31, 2020
Q3 2020 10.7 +2.24 +26.5% Sep 30, 2020
Q2 2020 9.73 +0.92 +10.4% Jun 30, 2020
Q1 2020 8.86 -0.98 -9.96% Mar 31, 2020
Q4 2019 8.96 -1.53 -14.6% Dec 31, 2019
Q3 2019 8.47 -1.11 -11.6% Sep 30, 2019
Q2 2019 8.82 -1.83 -17.2% Jun 30, 2019
Q1 2019 9.84 -3.25 -24.8% Mar 31, 2019
Q4 2018 10.5 -2.61 -19.9% Dec 31, 2018
Q3 2018 9.58 -8.07 -45.7% Sep 30, 2018
Q2 2018 10.7 -7.09 -40% Jun 30, 2018
Q1 2018 13.1 -5.3 -28.8% Mar 31, 2018
Q4 2017 13.1 -4.87 -27.1% Dec 31, 2017
Q3 2017 17.7 +4.55 +34.7% Sep 30, 2017
Q2 2017 17.7 +7.57 +74.4% Jun 30, 2017
Q1 2017 18.4 +9.17 +99.4% Mar 31, 2017
Q4 2016 18 +9.42 +110% Dec 31, 2016
Q3 2016 13.1 +3.41 +35.1% Sep 30, 2016
Q2 2016 10.2 -2.37 -18.9% Jun 30, 2016
Q1 2016 9.22 -35.7 -79.5% Mar 31, 2016
Q4 2015 8.55 -111 -92.9% Dec 31, 2015
Q3 2015 9.7 -155 -94.1% Sep 30, 2015
Q2 2015 12.5 -796 -98.4% Jun 30, 2015
Q1 2015 44.9 -586 -92.9% Mar 31, 2015
Q4 2014 120 Dec 31, 2014
Q3 2014 165 Sep 30, 2014
Q2 2014 809 Jun 30, 2014
Q1 2014 631 Mar 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.